<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27994281</article-id><article-id pub-id-type="pmc">5153932</article-id><article-id pub-id-type="publisher-id">BLT.16.175950</article-id><article-id pub-id-type="doi">10.2471/BLT.16.175950</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Assay optimization for molecular detection of Zika virus</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Optimisation des tests pour la d&#x000e9;tection mol&#x000e9;culaire du virus Zika</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Optimizaci&#x000f3;n de la prueba para la detecci&#x000f3;n molecular del virus de Zika</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062e;&#x00635;&#x00635;&#x00629; &#x00644;&#x00644;&#x00643;&#x00634;&#x00641; &#x00627;&#x00644;&#x0062c;&#x00632;&#x0064a;&#x00626;&#x0064a; &#x00639;&#x00646; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x000a0;&#x00632;&#x0064a;&#x00643;&#x00627; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x05206;&#x05b50;&#x068c0;&#x06d4b;&#x07684;&#x08bd5;&#x09a8c;&#x04f18;&#x05316;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x0041e;&#x0043f;&#x00442;&#x00438;&#x0043c;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x0044f; &#x0043c;&#x0043e;&#x0043b;&#x00435;&#x0043a;&#x00443;&#x0043b;&#x0044f;&#x00440;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00417;&#x00438;&#x0043a;&#x00430;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Victor M Corman et al.</alt-title><alt-title alt-title-type="title-running-head">Zika virus detection and viral load</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Corman</surname><given-names>Victor M</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rasche</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Baronti</surname><given-names>Cecile</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aldabbagh</surname><given-names>Souhaib</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cadar</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reusken</surname><given-names>Chantal BEM</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pas</surname><given-names>Suzan D</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Goorhuis</surname><given-names>Abraham</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schinkel</surname><given-names>Janke</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Molenkamp</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>K&#x000fc;mmerer</surname><given-names>Beate M</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bleicker</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Br&#x000fc;nink</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Eschbach-Bludau</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Eis-H&#x000fc;binger</surname><given-names>Anna M</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koopmans</surname><given-names>Marion P</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schmidt-Chanasit</surname><given-names>Jonas</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grobusch</surname><given-names>Martin P</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Lamballerie</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Drosten</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Drexler</surname><given-names>Jan Felix</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Institute of Virology, University of Bonn Medical Centre, Sigmund Freud-Str. 25, 53127 Bonn, <country>Germany</country>.</aff><aff id="aff2"><label>b</label>UMR EPV Emergence des Pathologies Virales, Aix Marseille Universit&#x000e9;, Marseille, <country>France</country>.</aff><aff id="aff3"><label>c</label>Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Centre for Arbovirus and Hemorrhagic Fever Reference and Research, Hamburg, <country>Germany</country>.</aff><aff id="aff4"><label>d</label>Erasmus MC, Department of Viroscience, Rotterdam, <country>Netherlands</country>.</aff><aff id="aff5"><label>e</label>Department of Infectious Diseases, University of Amsterdam, Amsterdam, <country>Netherlands</country>.</aff><aff id="aff6"><label>f</label>Clinical Virology Laboratory, University of Amsterdam, Amsterdam, <country>Netherlands</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Jan Felix Drexler (email: <email xlink:href="drexler@virology-bonn.de">drexler@virology-bonn.de</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="epreprint"><day>19</day><month>4</month><year>2016</year></pub-date><volume>94</volume><issue>12</issue><fpage>880</fpage><lpage>892</lpage><history><date date-type="received"><day>18</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>25</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>02</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>(c) 2016 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To examine the diagnostic performance of real-time reverse transcription (RT)-polymerase chain reaction (PCR) assays for Zika virus detection.</p></sec><sec><title>Methods</title><p>We compared seven published real-time RT&#x02013;PCR assays and two new assays that we have developed. To determine the analytical sensitivity of each assay, we constructed a synthetic universal control ribonucleic acid (uncRNA) containing all of the assays&#x02019; target regions on one RNA strand and spiked human blood or urine with known quantities of African or Asian Zika virus strains. Viral loads in 33 samples from Zika virus-infected patients were determined by using one of the new assays.</p></sec><sec><title>Findings</title><p>Oligonucleotides of the published real-time RT&#x02013;PCR assays, showed up to 10 potential mismatches with the Asian lineage causing the current outbreak, compared with 0 to 4 mismatches for the new assays. The 95% lower detection limit of the seven most sensitive assays ranged from 2.1 to 12.1 uncRNA copies/reaction. Two assays had lower sensitivities of 17.0 and 1373.3 uncRNA copies/reaction and showed a similar sensitivity when using spiked samples. The mean viral loads in samples from Zika virus-infected patients were 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> RNA copies/mL of blood and 2&#x02009;&#x000d7;&#x02009;10<sup>4</sup> RNA copies/mL of urine.</p></sec><sec><title>Conclusion</title><p>We provide reagents and updated protocols for Zika virus detection suitable for the current outbreak strains. Some published assays might be unsuitable for Zika virus detection, due to the limited sensitivity and potential incompatibility with some strains. Viral concentrations in the clinical samples were close to the technical detection limit, suggesting that the use of insensitive assays will cause false-negative results.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>&#x000c9;tudier la performance diagnostique des tests bas&#x000e9;s sur l'amplification en cha&#x000ee;ne par polym&#x000e9;rase (PCR) en temps r&#x000e9;el apr&#x000e8;s transcription inverse (RT) pour d&#x000e9;tecter le virus Zika.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons compar&#x000e9; sept tests publi&#x000e9;s utilisant la RT-PCR en temps r&#x000e9;el et deux nouveaux tests d&#x000e9;velopp&#x000e9;s par nos soins. Afin de d&#x000e9;terminer la sensibilit&#x000e9; analytique de chaque test, nous avons con&#x000e7;u un acide ribonucl&#x000e9;ique synth&#x000e9;tique de contr&#x000f4;le universel (ARNcun) contenant toutes les r&#x000e9;gions cibl&#x000e9;es par les tests sur une h&#x000e9;lice ARN et enrichi de l&#x02019;urine ou du sang humain de quantit&#x000e9;s connues de souches africaines ou asiatiques du virus Zika. Les charges virales dans 33&#x000a0;&#x000e9;chantillons provenant de patients infect&#x000e9;s par le virus Zika ont &#x000e9;t&#x000e9; d&#x000e9;termin&#x000e9;es &#x000e0; l'aide de l'un des nouveaux tests.</p></sec><sec><title>R&#x000e9;sultats</title><p>Les oligonucl&#x000e9;otides des tests publi&#x000e9;s utilisant la RT-PCR en temps r&#x000e9;el ont pr&#x000e9;sent&#x000e9; jusqu'&#x000e0; 10&#x000a0;mauvais appariements potentiels avec la lign&#x000e9;e asiatique provoquant l'&#x000e9;pid&#x000e9;mie actuelle, alors qu'on a constat&#x000e9; de 0&#x000a0;&#x000e0; 4&#x000a0;mauvais appariements dans le cas des nouveaux tests. La limite de d&#x000e9;tection inf&#x000e9;rieure &#x000e0;&#x000a0;95% des sept tests les plus sensibles variait de 2,1&#x000a0;&#x000e0; 12,1&#x000a0;copies d'ARNcun/r&#x000e9;action. Deux tests pr&#x000e9;sentaient des sensibilit&#x000e9;s plus basses de&#x000a0;17,0 et&#x000a0;1373,3&#x000a0;copies d'ARNcun/r&#x000e9;action et montraient une sensibilit&#x000e9; similaire lorsque des &#x000e9;chantillons enrichis &#x000e9;taient utilis&#x000e9;s. Les charges virales moyennes dans les &#x000e9;chantillons provenant de patients infect&#x000e9;s par le virus Zika &#x000e9;taient de&#x000a0;5&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup>&#x000a0;copies d'ARN/mL de sang et de&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>4</sup>&#x000a0;copies d'ARN/mL d'urine.</p></sec><sec><title>Conclusion</title><p>Nous proposons pour d&#x000e9;tecter le virus Zika des r&#x000e9;actifs et des protocoles actualis&#x000e9;s, adapt&#x000e9;s aux souches responsables de la flamb&#x000e9;e actuelle. Tous les tests publi&#x000e9;s ne permettent pas de d&#x000e9;tecter le virus Zika en raison d'une sensibilit&#x000e9; limit&#x000e9;e et d'une incompatibilit&#x000e9; potentielle avec certaines souches. Les concentrations virales dans les &#x000e9;chantillons cliniques &#x000e9;taient proches de la limite de d&#x000e9;tection technique, ce qui laisse penser que l'utilisation de tests insensibles donnera des r&#x000e9;sultats faussement n&#x000e9;gatifs.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Examinar el rendimiento del diagn&#x000f3;stico de las pruebas de reacci&#x000f3;n en cadena de la polimerasa de transcriptasa inversa (RT-PCR) en tiempo real para la detecci&#x000f3;n del virus de Zika.</p></sec><sec><title>M&#x000e9;todos</title><p>Se compararon siete pruebas de RT-PCR en tiempo real publicadas y dos pruebas nuevas que se han desarrollado. Con el fin de determinar la sensibilidad anal&#x000ed;tica de cada prueba, se construy&#x000f3; un &#x000e1;cido ribonucleico sint&#x000e9;tico de control universal (uncRNA) que conten&#x000ed;a todas las regiones objetivo de las pruebas en una hebra de RNA y se a&#x000f1;adi&#x000f3; a sangre u orina humana con cantidades conocidas de cepas de virus de Zika de Asia o &#x000c1;frica. Se determinaron las cargas v&#x000ed;ricas en 33 muestras procedentes de pacientes infectados por el virus de Zika a trav&#x000e9;s de una de las pruebas nuevas.</p></sec><sec><title>Resultados</title><p>Los oligonucle&#x000f3;tidos de las pruebas de RT-PCR en tiempo real publicadas mostraron hasta 10 posibles discordancias con el linaje de Asia causante de los brotes actuales, en comparaci&#x000f3;n con 0 de 4 discordancias en el caso de las pruebas nuevas. El l&#x000ed;mite de detecci&#x000f3;n inferior del 95% de las siete pruebas m&#x000e1;s sensibles abarc&#x000f3; de 2,1 a 12,1 copias/reacci&#x000f3;n de uncRNA. Dos pruebas mostraron sensibilidades inferiores de 17,0 y 1373,3 copias/reacci&#x000f3;n de uncRNA y presentaron una sensibilidad similar al usar muestras infectadas. Las cargas v&#x000ed;ricas medias en las muestras procedentes de pacientes infectados por el virus de Zika fueron de 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> copias de RNA/mL de sangre y de 2&#x02009;&#x000d7;&#x02009;10<sup>4</sup> copias de RNA/ml de orina.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Se proporcionan reactivos y protocolos actualizados para la detecci&#x000f3;n adecuada del virus de Zika en el caso de las cepas de brotes actuales. Algunas pruebas publicadas pueden no ser adecuadas para la detecci&#x000f3;n del virus de Zika, debido a la limitada sensibilidad y a la posible incompatibilidad con algunas cepas. Las concentraciones v&#x000ed;ricas en las muestras cl&#x000ed;nicas se acercaron al l&#x000ed;mite de detecci&#x000f3;n t&#x000e9;cnico, lo que suger&#x000ed;a que el uso de pruebas intensivas causar&#x000ed;a resultados falsos negativos.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062a;&#x00634;&#x0062e;&#x0064a;&#x00635;&#x0064a; &#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x0062a;&#x00641;&#x00627;&#x00639;&#x00644; &#x00627;&#x00644;&#x00628;&#x00648;&#x00644;&#x0064a;&#x00645;&#x0064a;&#x00631;&#x00627;&#x00632; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00633;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00644;&#x0062d;&#x00638;&#x0064a; (PCR) &#x00645;&#x00639; &#x00625;&#x00646;&#x00632;&#x0064a;&#x00645; &#x00627;&#x00644;&#x00646;&#x00633;&#x0062e; &#x00627;&#x00644;&#x00639;&#x00643;&#x00633;&#x0064a; (RT) &#x00644;&#x00627;&#x00643;&#x0062a;&#x00634;&#x00627;&#x00641; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x00625;&#x0062c;&#x00631;&#x00627;&#x00621; &#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00633;&#x00628;&#x00639;&#x00629; &#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00645;&#x00646;&#x00634;&#x00648;&#x00631;&#x00629; &#x00644;&#x0062a;&#x00641;&#x00627;&#x00639;&#x00644; &#x00627;&#x00644;&#x00628;&#x00648;&#x00644;&#x0064a;&#x00645;&#x0064a;&#x00631;&#x00627;&#x00632; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00633;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00644;&#x0062d;&#x00638;&#x0064a; &#x00645;&#x00639; &#x00625;&#x00646;&#x00632;&#x0064a;&#x00645; &#x00627;&#x00644;&#x00646;&#x00633;&#x0062e; &#x00627;&#x00644;&#x00639;&#x00643;&#x00633;&#x0064a; (RT&#x02011;PCR) &#x00648;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x0064a;&#x00646; &#x0062c;&#x0062f;&#x0064a;&#x0062f;&#x0064a;&#x00646; &#x0062a;&#x00645; &#x00625;&#x00639;&#x0062f;&#x00627;&#x0062f;&#x00647;&#x00645;&#x00627; &#x00645;&#x00646; &#x0062c;&#x00627;&#x00646;&#x00628;&#x00646;&#x00627;. &#x00648;&#x00644;&#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;&#x0064a;&#x00629; &#x00644;&#x00643;&#x00644; &#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x0060c; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00643;&#x00648;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062d;&#x00645;&#x00636; &#x00627;&#x00644;&#x00646;&#x00648;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00631;&#x0064a;&#x00628;&#x00648;&#x00632;&#x0064a; &#x00627;&#x00644;&#x00627;&#x00635;&#x00637;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00644;&#x00644;&#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00645;&#x00629; (uncRNA) &#x00648;&#x00627;&#x00644;&#x00630;&#x0064a; &#x0064a;&#x0062d;&#x0062a;&#x00648;&#x0064a; &#x00639;&#x00644;&#x00649; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00637;&#x00642; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00647;&#x0062f;&#x00641;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631; &#x00641;&#x0064a; &#x00634;&#x00631;&#x0064a;&#x00637; RNA &#x00648;&#x00627;&#x0062d;&#x0062f; &#x00648;&#x0064a;&#x0062d;&#x0062a;&#x00648;&#x0064a; &#x00639;&#x00644;&#x00649; &#x00645;&#x00624;&#x00634;&#x00631;&#x00627;&#x0062a; &#x00644;&#x00644;&#x0062f;&#x00645; &#x00623;&#x00648; &#x00627;&#x00644;&#x00628;&#x00648;&#x00644; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00627;&#x00644;&#x00630;&#x0064a; &#x0064a;&#x0062d;&#x0062a;&#x00648;&#x0064a; &#x00639;&#x00644;&#x00649; &#x00643;&#x00645;&#x0064a;&#x00627;&#x0062a; &#x00645;&#x00639;&#x00631;&#x00648;&#x00641;&#x00629; &#x00645;&#x00646; &#x00633;&#x00644;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00637;&#x00642;&#x00629; &#x00623;&#x00641;&#x00631;&#x0064a;&#x00642;&#x0064a;&#x00627; &#x00623;&#x00648; &#x00622;&#x00633;&#x0064a;&#x00627;. &#x00648;&#x0062a;&#x00645; &#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x0062d;&#x00645;&#x00648;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x0064a;&#x00629; &#x00641;&#x0064a; 33 &#x00639;&#x0064a;&#x00646;&#x00629; &#x00635;&#x00627;&#x0062f;&#x00631;&#x00629; &#x00645;&#x00646; &#x00645;&#x00631;&#x00636;&#x00649; &#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00623;&#x0062d;&#x0062f; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062c;&#x0062f;&#x0064a;&#x0062f;&#x00629;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p> &#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00648;&#x00644;&#x0064a;&#x0063a;&#x00648;&#x00646;&#x0064a;&#x00643;&#x00644;&#x0064a;&#x00648;&#x0062a;&#x0064a;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x0062a;&#x00641;&#x00627;&#x00639;&#x00644; &#x00627;&#x00644;&#x00628;&#x00648;&#x00644;&#x0064a;&#x00645;&#x0064a;&#x00631;&#x00627;&#x00632; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00633;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00644;&#x0062d;&#x00638;&#x0064a; &#x00645;&#x00639; &#x00625;&#x00646;&#x00632;&#x0064a;&#x00645; &#x00627;&#x00644;&#x00646;&#x00633;&#x0062e; &#x00627;&#x00644;&#x00639;&#x00643;&#x00633;&#x0064a; &#x00645;&#x00627; &#x0064a;&#x00635;&#x00644; &#x00625;&#x00644;&#x00649; 10 &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00645;&#x0062d;&#x0062a;&#x00645;&#x00644;&#x00629; &#x00645;&#x00646; &#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x0062a;&#x00637;&#x00627;&#x00628;&#x00642; &#x00645;&#x00639; &#x00627;&#x00644;&#x00633;&#x00644;&#x00627;&#x00644;&#x00629; &#x00627;&#x00644;&#x00622;&#x00633;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00633;&#x00628;&#x00628;&#x00629; &#x00644;&#x00644;&#x00639;&#x0062f;&#x00648;&#x00649; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x0064a;&#x00629;&#x0060c; &#x00628;&#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x00645;&#x00639; &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x0062a;&#x00637;&#x00627;&#x00628;&#x00642; &#x00628;&#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x00629; &#x00644;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062c;&#x0062f;&#x0064a;&#x0062f;&#x00629; &#x00628;&#x00645;&#x00639;&#x0062f;&#x00644; 0 &#x00625;&#x00644;&#x00649; 4. &#x0062a;&#x00631;&#x00627;&#x00648;&#x0062d; &#x0062d;&#x0062f; &#x00627;&#x00644;&#x00627;&#x00643;&#x0062a;&#x00634;&#x00627;&#x00641; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636; &#x00628;&#x00646;&#x00633;&#x00628;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x0200f;% </styled-content>&#x00641;&#x0064a; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x00628;&#x00639;&#x00629; &#x00627;&#x00644;&#x00623;&#x00643;&#x0062b;&#x00631; &#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00645;&#x00646; 2.1 &#x00625;&#x00644;&#x00649; 12.1 &#x00645;&#x00646; &#x00646;&#x00633;&#x0062e; &#x00633;&#x00644;&#x00627;&#x00644;&#x00627;&#x0062a; uncRNA &#x00644;&#x0062a;&#x00641;&#x00627;&#x00639;&#x00644; &#x00643;&#x00644; &#x0062d;&#x00627;&#x00644;&#x00629;. &#x00648;&#x0064f;&#x0062c;&#x0062f; &#x00644;&#x0062f;&#x00649; &#x00627;&#x0062b;&#x00646;&#x0064a;&#x00646; &#x00645;&#x00646; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x0062f;&#x00631;&#x0062c;&#x00627;&#x0062a; &#x00645;&#x00646;&#x0062e;&#x00641;&#x00636;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00628;&#x00645;&#x00642;&#x0062f;&#x00627;&#x00631; 17.0 &#x00648;1373.3 &#x00644;&#x00646;&#x00633;&#x0062e; &#x00633;&#x00644;&#x00627;&#x00644;&#x00627;&#x0062a; uncRNA &#x00644;&#x0062a;&#x00641;&#x00627;&#x00639;&#x00644; &#x00643;&#x00644; &#x0062d;&#x00627;&#x00644;&#x00629; &#x00648;&#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x00648;&#x0062c;&#x00648;&#x0062f; &#x0062f;&#x00631;&#x0062c;&#x00629; &#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00645;&#x00645;&#x00627;&#x0062b;&#x00644;&#x00629; &#x00639;&#x00646;&#x0062f; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00639;&#x0064a;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00624;&#x00634;&#x00631;&#x00627;&#x0062a;. &#x00628;&#x00644;&#x0063a; &#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x00627;&#x00644;&#x0062d;&#x00645;&#x00648;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00639;&#x0064a;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00635;&#x00627;&#x0062f;&#x00631;&#x00629; &#x00639;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627; 5 &#x000d7; 10 <sup>4 </sup> &#x00646;&#x00633;&#x0062e; &#x00645;&#x00646; RNA &#x00644;&#x00643;&#x00644; &#x00645;&#x00644;&#x00644;&#x0064a;&#x00644;&#x0062a;&#x00631; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00645; &#x00648; 2&#x02009;&#x000d7;&#x02009;10 <sup>4 </sup> &#x00646;&#x00633;&#x0062e; &#x00645;&#x00646; RNA &#x00644;&#x00643;&#x00644; &#x00645;&#x00644;&#x00644;&#x0064a;&#x00644;&#x0062a;&#x00631; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00648;&#x00644;. </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x00646;&#x0062d;&#x00646; &#x00646;&#x00648;&#x00641;&#x00631; &#x00627;&#x00644;&#x00643;&#x00627;&#x00634;&#x00641;&#x00627;&#x0062a; &#x00648;&#x00623;&#x0062d;&#x0062f;&#x0062b; &#x00627;&#x00644;&#x00628;&#x00631;&#x00648;&#x0062a;&#x00648;&#x00643;&#x00648;&#x00644;&#x00627;&#x0062a; &#x00644;&#x00627;&#x00643;&#x0062a;&#x00634;&#x00627;&#x00641; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627; &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00646;&#x00627;&#x00633;&#x00628; &#x00633;&#x00644;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00639;&#x0062f;&#x00648;&#x00649; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x0064a;&#x00629;. &#x00648;&#x00642;&#x0062f; &#x0062a;&#x00643;&#x00648;&#x00646; &#x00628;&#x00639;&#x00636; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00646;&#x00634;&#x00648;&#x00631;&#x00629; &#x0063a;&#x0064a;&#x00631; &#x00645;&#x00646;&#x00627;&#x00633;&#x00628;&#x00629; &#x00644;&#x00627;&#x00643;&#x0062a;&#x00634;&#x00627;&#x00641; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00632;&#x0064a;&#x00643;&#x00627; &#x00646;&#x00638;&#x00631;&#x0064b;&#x00627; &#x00644;&#x00648;&#x0062c;&#x00648;&#x0062f; &#x0062f;&#x00631;&#x0062c;&#x00629; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00648;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;&#x0064a;&#x00629; &#x00639;&#x0062f;&#x00645; &#x0062a;&#x00648;&#x00627;&#x00641;&#x00642;&#x00647;&#x00627; &#x00645;&#x00639; &#x00628;&#x00639;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644;&#x00627;&#x00644;&#x00627;&#x0062a;. &#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x00633;&#x00628; &#x0062a;&#x00631;&#x00643;&#x0064a;&#x00632; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00639;&#x0064a;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644;&#x0064a;&#x00629; &#x00642;&#x00631;&#x0064a;&#x00628;&#x00629; &#x00645;&#x00646; &#x0062d;&#x0062f; &#x00627;&#x00644;&#x00627;&#x00643;&#x0062a;&#x00634;&#x00627;&#x00641; &#x00627;&#x00644;&#x0062a;&#x00642;&#x00646;&#x0064a;&#x0060c; &#x00645;&#x00645;&#x00627; &#x0064a;&#x00634;&#x0064a;&#x00631; &#x00625;&#x00644;&#x00649; &#x00623;&#x00646; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00641;&#x0062a;&#x00642;&#x0062f; &#x00625;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00633;&#x0064a;&#x00624;&#x0062f;&#x0064a; &#x00625;&#x00644;&#x00649; &#x00625;&#x00635;&#x0062f;&#x00627;&#x00631; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x0062e;&#x00627;&#x00637;&#x00626;&#x00629; &#x00648;&#x00633;&#x00644;&#x00628;&#x0064a;&#x00629;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x065e8;&#x05728;&#x068c0;&#x067e5;&#x09488;&#x05bf9;&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x068c0;&#x06d4b;&#x07684;&#x05b9e;&#x065f6;&#x09006;&#x08f6c;&#x05f55;&#x000a0;(RT)-&#x0805a;&#x05408;&#x09176;&#x094fe;&#x053cd;&#x05e94;&#x000a0;(PCR)&#x000a0;&#x08bd5;&#x09a8c;&#x07684;&#x08bca;&#x065ad;&#x06027;&#x080fd;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x06211;&#x04eec;&#x06bd4;&#x08f83;&#x04e86;&#x000a0;7&#x000a0;&#x079cd;&#x0516c;&#x05e03;&#x07684;&#x05b9e;&#x065f6;&#x000a0;RT-PCR&#x000a0;&#x08bd5;&#x09a8c;&#x0548c;&#x06211;&#x04eec;&#x05f00;&#x053d1;&#x07684;&#x04e24;&#x079cd;&#x065b0;&#x08bd5;&#x09a8c;&#x03002; &#x04e3a;&#x04e86;&#x0786e;&#x05b9a;&#x05404;&#x079cd;&#x08bd5;&#x09a8c;&#x07684;&#x05206;&#x06790;&#x07075;&#x0654f;&#x05ea6;&#x0ff0c;&#x06211;&#x04eec;&#x06784;&#x05efa;&#x04e86;&#x05728;&#x04e00;&#x04e2a;&#x000a0;RNA&#x000a0;&#x094fe;&#x04e0a;&#x05305;&#x0542b;&#x06240;&#x06709;&#x08bd5;&#x09a8c;&#x076ee;&#x06807;&#x0533a;&#x057df;&#x07684;&#x05408;&#x06210;&#x0901a;&#x07528;&#x05bf9;&#x07167;&#x06838;&#x07cd6;&#x06838;&#x09178;&#x000a0;(uncRNA)&#x000a0;&#x04ee5;&#x053ca;&#x05e26;&#x06709;&#x05df2;&#x077e5;&#x06570;&#x091cf;&#x07684;&#x0975e;&#x06d32;&#x06216;&#x04e9a;&#x06d32;&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x0682a;&#x07684;&#x052a0;&#x06807;&#x04eba;&#x04f53;&#x08840;&#x06db2;&#x06216;&#x05c3f;&#x06db2;&#x03002; &#x0901a;&#x08fc7;&#x04f7f;&#x07528;&#x04e00;&#x079cd;&#x065b0;&#x07684;&#x08bd5;&#x09a8c;&#x06d4b;&#x05b9a;&#x000a0;33&#x000a0;&#x04e2a;&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x0611f;&#x067d3;&#x060a3;&#x08005;&#x06837;&#x0672c;&#x07684;&#x075c5;&#x06bd2;&#x08f7d;&#x091cf;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x05df2;&#x0516c;&#x05e03;&#x07684;&#x05b9e;&#x065f6;&#x000a0;RT-PCR&#x000a0;&#x08bd5;&#x09a8c;&#x07684;&#x05be1;&#x06838;&#x082f7;&#x09178;&#x0ff0c;&#x0663e;&#x0793a;&#x051fa;&#x04e0e;&#x04e9a;&#x06d32;&#x08840;&#x07edf;&#x06f5c;&#x05728;&#x07684;&#x05931;&#x0914d;&#x07387;&#x09ad8;&#x08fbe;&#x000a0;10&#x0ff0c;&#x076f8;&#x06bd4;&#x04e4b;&#x04e0b;&#x0ff0c;&#x065b0;&#x08bd5;&#x09a8c;&#x07684;&#x05931;&#x0914d;&#x07387;&#x04e3a;&#x000a0;0&#x000a0;&#x081f3;&#x000a0;4&#x03002; &#x04e03;&#x079cd;&#x06700;&#x0654f;&#x0611f;&#x08bd5;&#x09a8c;&#x07684;&#x000a0;95%&#x000a0;&#x068c0;&#x06d4b;&#x04e0b;&#x09650;&#x08303;&#x056f4;&#x04e3a;&#x000a0;2.1&#x000a0;&#x081f3;&#x000a0;12.1&#x000a0;uncRNA&#x000a0;&#x062f7;&#x08d1d;/&#x053cd;&#x05e94;&#x03002; &#x04e24;&#x04e2a;&#x08bd5;&#x09a8c;&#x04e2d;&#x000a0;17.0&#x000a0;&#x0548c; 1373.3&#x000a0;uncRNA&#x000a0;&#x0590d;&#x05236;/&#x053cd;&#x05e94;&#x07684;&#x07075;&#x0654f;&#x05ea6;&#x08f83;&#x04f4e;&#x0ff0c;&#x04f7f;&#x07528;&#x052a0;&#x06807;&#x06837;&#x0672c;&#x065f6;&#x08868;&#x073b0;&#x051fa;&#x07c7b;&#x04f3c;&#x07684;&#x07075;&#x0654f;&#x05ea6;&#x03002; &#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x0611f;&#x067d3;&#x060a3;&#x08005;&#x07684;&#x06837;&#x0672c;&#x04e2d;&#x0ff0c;&#x08840;&#x06db2;&#x07684;&#x05e73;&#x05747;&#x075c5;&#x06bd2;&#x08f7d;&#x091cf;&#x04e3a;&#x000a0;5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x000a0;RNA&#x000a0;&#x062f7;&#x08d1d;/&#x06beb;&#x05347;&#x0ff0c;&#x05c3f;&#x06db2;&#x07684;&#x05e73;&#x05747;&#x075c5;&#x06bd2;&#x08f7d;&#x091cf;&#x04e3a;&#x000a0;2&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x000a0;&#x062f7;&#x08d1d;/&#x06beb;&#x05347;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x06211;&#x04eec;&#x04e3a;&#x09002;&#x05408;&#x05f53;&#x0524d;&#x075ab;&#x060c5;&#x07684;&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x068c0;&#x06d4b;&#x063d0;&#x04f9b;&#x08bd5;&#x05242;&#x0548c;&#x066f4;&#x065b0;&#x065b9;&#x06848;&#x03002; &#x07531;&#x04e8e;&#x06709;&#x09650;&#x07684;&#x07075;&#x0654f;&#x05ea6;&#x04ee5;&#x053ca;&#x04e0e;&#x04e00;&#x04e9b;&#x083cc;&#x0682a;&#x06f5c;&#x05728;&#x07684;&#x04e0d;&#x0517c;&#x05bb9;&#x06027;&#x0ff0c;&#x056e0;&#x06b64;&#x04e00;&#x04e9b;&#x0516c;&#x05e03;&#x07684;&#x08bd5;&#x09a8c;&#x053ef;&#x080fd;&#x04e0d;&#x09002;&#x05408;&#x05be8;&#x05361;&#x075c5;&#x06bd2;&#x068c0;&#x06d4b;&#x03002; &#x04e34;&#x05e8a;&#x06837;&#x0672c;&#x04e2d;&#x07684;&#x075c5;&#x06bd2;&#x0542b;&#x091cf;&#x063a5;&#x08fd1;&#x04e8e;&#x06280;&#x0672f;&#x068c0;&#x06d4b;&#x06781;&#x09650;&#x0ff0c;&#x08fd9;&#x08868;&#x0660e;&#x04f7f;&#x07528;&#x04e0d;&#x0654f;&#x0611f;&#x08bd5;&#x09a8c;&#x05c06;&#x04f1a;&#x05f15;&#x08d77;&#x05047;&#x09634;&#x06027;&#x07ed3;&#x0679c;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x00418;&#x00437;&#x00443;&#x00447;&#x00438;&#x00442;&#x0044c; &#x00434;&#x00438;&#x00430;&#x00433;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00432;&#x0043e;&#x00437;&#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00417;&#x00438;&#x0043a;&#x00430; &#x00441; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c;&#x0044e; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x0043c;&#x00435;&#x00440;&#x00430;&#x00437;&#x0043d;&#x0043e;&#x00439; &#x00446;&#x00435;&#x0043f;&#x0043d;&#x0043e;&#x00439; &#x00440;&#x00435;&#x00430;&#x0043a;&#x00446;&#x00438;&#x00438;&#x000a0;(&#x0041f;&#x00426;&#x00420;) &#x00441; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00442;&#x0043d;&#x0043e;&#x00439; &#x00442;&#x00440;&#x00430;&#x0043d;&#x00441;&#x0043a;&#x00440;&#x00438;&#x0043f;&#x00442;&#x00430;&#x00437;&#x0043e;&#x00439;&#x000a0;(&#x0041e;&#x00422;) &#x00432; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00435; &#x00440;&#x00435;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00432;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x00438;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00438;&#x0043b;&#x00438; &#x00441;&#x00435;&#x0043c;&#x0044c; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0041e;&#x00422;-&#x0041f;&#x00426;&#x00420;, &#x00441;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043e; &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00445; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0044b; &#x00432; &#x0043b;&#x00438;&#x00442;&#x00435;&#x00440;&#x00430;&#x00442;&#x00443;&#x00440;&#x00435;, &#x00438; &#x00434;&#x00432;&#x00430; &#x0043d;&#x0043e;&#x00432;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x00430;, &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00430;&#x00432;&#x00442;&#x0043e;&#x00440;&#x00430;&#x0043c;&#x00438;. &#x00414;&#x0043b;&#x0044f; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043a;&#x00430;&#x00436;&#x00434;&#x0043e;&#x00433;&#x0043e; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x00430; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00441;&#x0043a;&#x0043e;&#x0043d;&#x00441;&#x00442;&#x00440;&#x00443;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0044b; &#x00441;&#x00438;&#x0043d;&#x00442;&#x00435;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00443;&#x0043d;&#x00438;&#x00432;&#x00435;&#x00440;&#x00441;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00435; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00435; &#x00440;&#x00438;&#x00431;&#x0043e;&#x0043d;&#x00443;&#x0043a;&#x0043b;&#x00435;&#x00438;&#x0043d;&#x0043e;&#x00432;&#x0044b;&#x00435; &#x0043a;&#x00438;&#x00441;&#x0043b;&#x0043e;&#x00442;&#x0044b;&#x000a0;(&#x00443;&#x0043d;&#x0043a;&#x00420;&#x0041d;&#x0041a;), &#x00441;&#x0043e;&#x00434;&#x00435;&#x00440;&#x00436;&#x00430;&#x00449;&#x00438;&#x00435; &#x00432;&#x00441;&#x00435; &#x00446;&#x00435;&#x0043b;&#x00435;&#x00432;&#x0044b;&#x00435; &#x00443;&#x00447;&#x00430;&#x00441;&#x00442;&#x0043a;&#x00438; &#x0043d;&#x00430; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00439; &#x00438;&#x00437; &#x00446;&#x00435;&#x0043f;&#x00435;&#x00439; &#x00420;&#x0041d;&#x0041a;. &#x0042d;&#x00442;&#x00438; &#x00420;&#x0041d;&#x0041a; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00434;&#x0043e;&#x00431;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0044b; &#x0043a; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00446;&#x00430;&#x0043c; &#x0043a;&#x00440;&#x0043e;&#x00432;&#x00438; &#x00438;&#x0043b;&#x00438; &#x0043c;&#x0043e;&#x00447;&#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432;, &#x00441;&#x0043e;&#x00434;&#x00435;&#x00440;&#x00436;&#x00430;&#x00449;&#x00438;&#x00445; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441; &#x00417;&#x00438;&#x0043a;&#x00430; &#x00430;&#x00444;&#x00440;&#x00438;&#x0043a;&#x00430;&#x0043d;&#x00441;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x0043b;&#x00438; &#x00430;&#x00437;&#x00438;&#x00430;&#x00442;&#x00441;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00440;&#x0043e;&#x00438;&#x00441;&#x00445;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432; &#x00438;&#x00437;&#x00432;&#x00435;&#x00441;&#x00442;&#x0043d;&#x0044b;&#x00445; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00430;&#x00445;. &#x0041e;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00438;&#x00437; &#x0043d;&#x0043e;&#x00432;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x0044f;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043d;&#x00430;&#x0044f; &#x0043d;&#x00430;&#x00433;&#x00440;&#x00443;&#x00437;&#x0043a;&#x00430; &#x00434;&#x0043b;&#x0044f; 33&#x000a0;&#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00446;&#x0043e;&#x00432; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432;, &#x00437;&#x00430;&#x00440;&#x00430;&#x00436;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043e;&#x0043c; &#x00417;&#x00438;&#x0043a;&#x00430;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x0041e;&#x0043b;&#x00438;&#x00433;&#x0043e;&#x0043d;&#x00443;&#x0043a;&#x0043b;&#x00435;&#x0043e;&#x00442;&#x00438;&#x00434;&#x0044b; &#x00434;&#x0043b;&#x0044f; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0041e;&#x00422;-&#x0041f;&#x00426;&#x00420; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x0043b;&#x00438; &#x00434;&#x0043e; 10&#x000a0;&#x0043f;&#x0043e;&#x00442;&#x00435;&#x0043d;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043d;&#x00435;&#x00441;&#x0043e;&#x00432;&#x0043f;&#x00430;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00439; &#x0043f;&#x00440;&#x00438; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00430;&#x00437;&#x00438;&#x00430;&#x00442;&#x00441;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00440;&#x0043e;&#x00438;&#x00441;&#x00445;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f;, &#x00432;&#x0044b;&#x00437;&#x00432;&#x00430;&#x00432;&#x00448;&#x00435;&#x00433;&#x0043e; &#x0043d;&#x0044b;&#x0043d;&#x00435;&#x00448;&#x0043d;&#x0044e;&#x0044e; &#x00432;&#x00441;&#x0043f;&#x0044b;&#x00448;&#x0043a;&#x00443; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x00435;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438;, &#x00442;&#x0043e;&#x00433;&#x00434;&#x00430; &#x0043a;&#x00430;&#x0043a; &#x0043d;&#x0043e;&#x00432;&#x0044b;&#x00435; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x0043b;&#x00438; &#x0043e;&#x00442; 0 &#x00434;&#x0043e; 4&#x000a0;&#x0043d;&#x00435;&#x00441;&#x0043e;&#x00432;&#x0043f;&#x00430;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00439;. &#x00414;&#x0043b;&#x0044f; &#x00441;&#x00435;&#x0043c;&#x00438; &#x0043d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x0043e;&#x00432; 95%-&#x00439; &#x0043d;&#x00438;&#x00436;&#x0043d;&#x00438;&#x00439; &#x0043f;&#x0043e;&#x00440;&#x0043e;&#x00433; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x0043b;&#x0044f;&#x0043b; &#x0043e;&#x00442; 2,1 &#x00434;&#x0043e; 12,1&#x000a0;&#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00438; &#x00443;&#x0043d;&#x0043a;&#x00420;&#x0041d;&#x0041a; &#x0043d;&#x00430; &#x00440;&#x00435;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0044e;. &#x00414;&#x00432;&#x00430; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00434;&#x00435;&#x0043c;&#x0043e;&#x0043d;&#x00441;&#x00442;&#x00440;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00443;&#x0044e; &#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x000a0;(&#x0043e;&#x00442; 17,0 &#x00434;&#x0043e; 1373,3&#x000a0;&#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00438; &#x00443;&#x0043d;&#x0043a;&#x00420;&#x0041d;&#x0041a; &#x0043d;&#x00430; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;) &#x00438; &#x00441;&#x00445;&#x0043e;&#x00434;&#x0043d;&#x00443;&#x0044e; &#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x0043f;&#x00440;&#x00438; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00446;&#x0043e;&#x00432; &#x00441; &#x00434;&#x0043e;&#x00431;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00443;&#x0043d;&#x0043a;&#x00420;&#x0041d;&#x0041a;. &#x00421;&#x00440;&#x00435;&#x00434;&#x0043d;&#x0044f;&#x0044f; &#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00438;&#x0043d;&#x00430; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043d;&#x0043e;&#x00439; &#x0043d;&#x00430;&#x00433;&#x00440;&#x00443;&#x00437;&#x0043a;&#x00438; &#x00432; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00446;&#x00430;&#x00445; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432;, &#x00438;&#x0043d;&#x00444;&#x00438;&#x00446;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043e;&#x0043c; &#x00417;&#x00438;&#x0043a;&#x00430;, &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x00438;&#x0043b;&#x00430; 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> &#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00439; &#x00420;&#x0041d;&#x0041a;/&#x0043c;&#x0043b; &#x00434;&#x0043b;&#x0044f; &#x0043a;&#x00440;&#x0043e;&#x00432;&#x00438; &#x00438; 2&#x02009;&#x000d7;&#x02009;10<sup>4 </sup>&#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00439;&#x00420;&#x0041d;&#x0041a;/&#x0043c;&#x0043b; &#x00434;&#x0043b;&#x0044f; &#x0043c;&#x0043e;&#x00447;&#x00438;.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043b;&#x00430;&#x00433;&#x00430;&#x0044e;&#x00442; &#x00440;&#x00435;&#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0044b; &#x00438; &#x0043e;&#x00431;&#x0043d;&#x0043e;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x0043e;&#x0043a;&#x0043e;&#x0043b;&#x0044b; &#x00434;&#x0043b;&#x0044f; &#x00432;&#x0044b;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00417;&#x00438;&#x0043a;&#x00430;, &#x00432;&#x0044b;&#x00437;&#x00432;&#x00430;&#x00432;&#x00448;&#x00435;&#x00433;&#x0043e; &#x0043d;&#x0044b;&#x0043d;&#x00435;&#x00448;&#x0043d;&#x0044e;&#x0044e; &#x00432;&#x00441;&#x0043f;&#x0044b;&#x00448;&#x0043a;&#x00443; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;. &#x0041d;&#x00435;&#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00438;&#x00437; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432;, &#x0043f;&#x0043e; &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x0043c; &#x00438;&#x0043c;&#x00435;&#x0044e;&#x00442;&#x00441;&#x0044f; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043b;&#x00438;&#x00442;&#x00435;&#x00440;&#x00430;&#x00442;&#x00443;&#x00440;&#x0043d;&#x0044b;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435;, &#x0043c;&#x0043e;&#x00433;&#x00443;&#x00442; &#x00431;&#x0044b;&#x00442;&#x0044c; &#x0043d;&#x00435;&#x0043f;&#x0043e;&#x00434;&#x00445;&#x0043e;&#x00434;&#x0044f;&#x00449;&#x00438;&#x0043c;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x00442;&#x00435;&#x0043a;&#x00443;&#x00449;&#x00435;&#x00439; &#x00441;&#x00438;&#x00442;&#x00443;&#x00430;&#x00446;&#x00438;&#x00438; &#x00438;&#x00437;-&#x00437;&#x00430; &#x0043e;&#x00433;&#x00440;&#x00430;&#x0043d;&#x00438;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00438; &#x0043f;&#x0043e;&#x00442;&#x00435;&#x0043d;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x0043d;&#x00435;&#x00441;&#x0043e;&#x00432;&#x0043c;&#x00435;&#x00441;&#x00442;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00441; &#x0043d;&#x00435;&#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x0043c;&#x00438; &#x00448;&#x00442;&#x00430;&#x0043c;&#x0043c;&#x00430;&#x0043c;&#x00438; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430;. &#x0041a;&#x0043e;&#x0043d;&#x00446;&#x00435;&#x0043d;&#x00442;&#x00440;&#x00430;&#x00446;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00432; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00430;&#x00445; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x00431;&#x0043b;&#x00438;&#x00437;&#x0043a;&#x00430; &#x0043a; &#x00442;&#x00435;&#x00445;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x0043c;&#x00443; &#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00443; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f;, &#x00447;&#x00442;&#x0043e; &#x0043f;&#x0043e;&#x00437;&#x00432;&#x0043e;&#x0043b;&#x0044f;&#x00435;&#x00442; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x0044c;, &#x00447;&#x00442;&#x0043e; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x0043d;&#x00435;&#x00447;&#x00443;&#x00432;&#x00441;&#x00442;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043c;&#x0043e;&#x00436;&#x00435;&#x00442; &#x0043f;&#x00440;&#x00438;&#x00432;&#x0043e;&#x00434;&#x00438;&#x00442;&#x0044c; &#x0043a; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x0043b;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x0043e;&#x00442;&#x00440;&#x00438;&#x00446;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00432;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The Zika virus is a mosquito-borne flavivirus with an approximately 11 kilobase ribonucleic acid (RNA) genome.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> The virus usually causes a mild infection in adults, symptoms include fever, arthralgia and rash.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="R3" ref-type="bibr"><sup>3</sup></xref> However, severe complications can occur, such as Guillain-Barr&#x000e9; syndrome,<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> meningoencephalitis,<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> hearing loss and uveitis.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="R7" ref-type="bibr"><sup>7</sup></xref> In the current Zika virus outbreak, intrauterine infections have been associated with fetal malformations.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref></p><p>Reliable detection of the Zika virus in infected people is key to understanding the epidemiology, the pathogenesis and alternative transmission routes of the virus, such as sexual intercourse and blood transfusions.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> However, in areas where the Zika virus is co-circulating with dengue and chikungunya viruses, physicians cannot reliably diagnose the Zika virus infection by clinical presentation, because the viruses cause similar symptoms. Using serology for Zika virus diagnostics can be challenging because of the cross-reactivity of antibodies elicited by other endemic flaviviruses &#x02013; such as dengue, yellow fever, St Louis encephalitis and West Nile viruses.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> Molecular detection of viral nucleic acid using real-time reverse transcription (RT)-polymerase chain reaction (PCR) assay is a highly reliable diagnostic method during acute infection. Currently, there are six widely used real-time RT&#x02013;PCR assays for Zika virus detection.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref> The Pan American Health Organization (PAHO) has recommended an additional real-time RT&#x02013;PCR assay.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref></p><p>High real-time RT&#x02013;PCR sensitivity is important to avoid false-negative results. Nucleotide mutations in the binding sites of primers and probes can affect the sensitivity.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> So far, the genetic variability of the Zika virus Asian lineage causing the current American outbreak is limited to about 2% nucleotide differences across the viral genome (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). However, mutations do not occur evenly across viral genomes. Up to 10 nucleotide mismatches between the oligonucleotide sequences of the published assays and the Asian lineage consensus sequence already exist and in individual primers or probes, there are up to five mismatches (<xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>). Note that these are worst-case scenarios based on the genetic variability permitted within the Asian Zika virus lineage, with no single known Zika virus strain accumulating all of these mismatches. However, the increasing number of divergent Zika virus outbreak strains highlights the genetic variability as a potential limiting factor of the sensitivity of Zika virus real-time RT&#x02013;PCR-based diagnostics.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Zika virus genomic identity plot</p></caption><p>Notes: Identity plot of all Zika virus polyprotein sequences characterized to at least 80% available at GenBank&#x000ae; by 13 April 2016. Similarity plots were done using SSE V1.2.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> A sliding window of 200 and a step size of 40 nucleotides were used.</p><graphic xlink:href="BLT.16.175950-F1"/></fig><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p><bold>Alignment of real-time reverse transcription polymerase chain reaction assays and Zika virus lineages</bold></p></caption><p>E: envelope; M: membrane; NS: nonstructural protein; </p><p>Oligo: oligonucleotide; PAHO: Pan American Health Organization; PCR: polymerase chain reaction; RNA; ribonucleic acid; seq: sequence.</p><p>Notes: For each of the African and Asian lineage, 100% consensus sequences were generated and mapped to respective PCR primers and probes. Consensus calculations included all 259 complete and partial Zika virus sequences available at GenBank&#x000ae; by 7 April 2016. Variable sites within the oligonucleotide binding sites of the two Zika virus lineages are highlighted in black, variable sites between the two lineages in grey. Potential mismatches in oligonucleotides are indicated by asterisks. Y&#x02009;=&#x02009;C/T, R&#x02009;=&#x02009;A/G, M&#x02009;=&#x02009;A/C, B&#x02009;=&#x02009;C/G/T, S&#x02009;=&#x02009;G/C, W&#x02009;=&#x02009;A/T, H&#x02009;=&#x02009;A/C/T, D&#x02009;=&#x02009;A/G/T, <italic>n</italic>&#x02009;=&#x02009;A/C/T/G, K&#x02009;=&#x02009;G/T, V&#x02009;=&#x02009;A/C/G. Locked nucleic acids in the probe of the Faye et al.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> NS5-based assay are underlined and a three nucleotide deletion in some African virus strains is boxed.</p><graphic xlink:href="BLT.16.175950-F2"/></fig><p>Here, we compare the sensitivity of published real-time RT&#x02013;PCR assays and two new assays, which we designed to have less nucleotide mismatches with the current outbreak strains. We also present data on viral load profiles in blood and urine from infected patients, using one of the new assays. </p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Assays</title><p>We compared nine different assays. We included all Zika virus real-time RT&#x02013;PCR assays published until 1 April 2016. These assays target the membrane (M), envelope (E), nonstructural protein (NS) 1, NS2b, NS3 and NS5 genomic domains.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref> We designed two new assays covering the currently known Zika virus genetic variability in the E and NS1 genomic domains (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). These novel assays showed up to four potential mismatches per assay (<xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>) and were designed to avoid mismatches in the most critical 3&#x02032;-terminal regions of oligonucleotides that affect primer binding the most.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> The new NS1 assay was additionally designed to allow cross-detection of the Spondweni virus &#x02013; the closest relative of the Zika virus &#x02013; because regions conserved between related virus taxa are expected to have less variation than other genomic regions.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Oligonucleotides used in Zika virus real-time reverse transcription polymerase chain reaction assays and potential nucleotide mismatches with Zika virus strains</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="100" span="1"/><col width="49" span="1"/><col width="52" span="1"/><col width="217" span="1"/><col width="260" span="1"/><col width="207" span="1"/><col width="163" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Assay, reference</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Target genomic domain (bases)<sup>a</sup></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">No. potential nucleotide mismatches<sup>a</sup><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Forward primer sequence (5&#x02018; to 3&#x02018;)</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Probe sequence (5&#x02018; to 3&#x02018;)<sup>b</sup></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Reverse primer sequence (5&#x02018; to 3&#x02018;)</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Control (covered genomic region, bases)<sup>a</sup></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">All Zika virus</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Asian lineage</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lanciotti M<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">M/E (939&#x02013;1015)</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">TTGGTCATGATACTGCTGATTGC</td><td valign="top" align="center" rowspan="1" colspan="1">CGGCATACAGCATCAGGTGCATAGGAG</td><td valign="top" align="center" rowspan="1" colspan="1">CCTTCCACAAAGTCCCTATTGC</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT I (811&#x02013;1500)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lanciotti E<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">E (1190&#x02013;1266)</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">CCGCTGCCCAACACAAG</td><td valign="top" align="center" rowspan="1" colspan="1">AGCCTACCTTGACAAGCAGTCAGACACTCAA</td><td valign="top" align="center" rowspan="1" colspan="1">CCACTAACGTTCTTTTGCAGACAT</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT I (811&#x02013;1500)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bonn E (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">E (1188&#x02013;1316)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">AGYCGYTGYCCAACACAAG</td><td valign="top" align="center" rowspan="1" colspan="1">CCTMCCTYGAYAAGCARTCAGACACYCAA</td><td valign="top" align="center" rowspan="1" colspan="1">CACCARRCTCCCYTTGCCA</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT I (811&#x02013;1500)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pyke E<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">E (1326&#x02013;1397)</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">AAGTTTGCATGCTCCAAGAAAAT</td><td valign="top" align="center" rowspan="1" colspan="1">ACCGGGAAGAGCATCCAGCCAGA</td><td valign="top" align="center" rowspan="1" colspan="1">CAGCATTATCCGGTACTCCAGAT</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT I (811&#x02013;1500)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pyke NS1<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">NS1 (3433&#x02013;3498)</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">GCACAATGCCCCCACTGT</td><td valign="top" align="center" rowspan="1" colspan="1">TTCCGGGCTAAAGATGGCTGTTGGT</td><td valign="top" align="center" rowspan="1" colspan="1">TGGGCCTTATCTCCATTCCA</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT II (3&#x02009;145&#x02013;3739)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bonn NS1 (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">NS1 (3385&#x02013;3495)</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">CRACYACTGCAAGYGGAAGG</td><td valign="top" align="center" rowspan="1" colspan="1">ATGGTGCTGYAGRGARTGCACAATGC</td><td valign="top" align="center" rowspan="1" colspan="1">GCCTTATCTCCATTCCATACC</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT II (3145&#x02013;3739)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAHO NS2b<xref rid="R12" ref-type="bibr"><sup>12</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">NS2b/NS3 (4538&#x02013;4628)</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">CTGTGGCATGAACCCAATAG</td><td valign="top" align="center" rowspan="1" colspan="1">CCACGCTCCAGCTGCAAAGG</td><td valign="top" align="center" rowspan="1" colspan="1">ATCCCATAGAGCACCACTCC</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT III (4246&#x02013;4882)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tappe NS3<xref rid="R7" ref-type="bibr"><sup>7</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">NS3 (6012&#x02013;6106)</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">TGGAGATGAGTACATGTATG</td><td valign="top" align="center" rowspan="1" colspan="1">CTGATGAAGGCCATGCACACTG</td><td valign="top" align="center" rowspan="1" colspan="1">GGTAGATGTTGTCAAGAAG</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT IV (&#x02009;770&#x02013;6370)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Faye NS5<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">NS5 (9376&#x02013;9477)</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">AARTACACATACCARAACAAAGTGGT</td><td valign="top" align="center" rowspan="1" colspan="1">CTYAGACCA<bold><underline>GCTG</underline></bold>AAR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">TCCRCTCCCYCTYTGGTCTTG</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA; IVT V (9100&#x02013;9696)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Marker assay 1 (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">M/NS1</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">GCATCCAGCCAGAGAATCTG</td><td valign="top" align="center" rowspan="1" colspan="1">TGCTGTCAGTTCACTCAAGGTTAGAGA</td><td valign="top" align="center" rowspan="1" colspan="1">CAATAACGGCTGGATCACACTC</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA (N/A)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Marker assay 2 (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">NS3/NS4b-NS5</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">CTTGACAATATTTACCTCCAAGATG</td><td valign="top" align="center" rowspan="1" colspan="1">CATAGCCTCGCTCTCTACACATGAGA</td><td valign="top" align="center" rowspan="1" colspan="1">GTTGCTTTTCGCTCCAGAGAC</td><td valign="top" align="center" rowspan="1" colspan="1">uncRNA (N/A)</td></tr></tbody></table><table-wrap-foot><p>E: envelope; IVT: in vitro transcribed ribonucleic acid; M: membrane; N/A: not applicable; NS: nonstructural protein; PAHO: Pan American Health Organization; uncRNA: universal control ribonucleic acid.</p><p><sup>a</sup> Nucleotide position according to GenBank&#x000ae; accession number: KU321639.</p><p><sup>b</sup> All probes are labelled with fluorescein amidite (FAM) at the 5&#x02032;-end and a Black Hole Quencher&#x000ae; at the 3&#x02032;-end.</p><p><sup>c</sup> Locked nucleic acid bases are underlined.</p></table-wrap-foot></table-wrap></sec><sec><title>Controls</title><p>All controls are based on a current Zika virus outbreak strain (GenBank&#x000ae; accession number KU321639). As positive controls, we generated five assay-specific quantified in vitro transcripts (IVT) for the respective genomic target regions. Data on analytical sensitivity, including the standardized measure lower limit of detection, are not available for most of the published assays. To enable stoichiometrically exact analyses of the lower limit of detection for all of the assays, we joined all target domains into a quantative universal control ribonucleic acid (uncRNA) containing all of the assays&#x02019; target regions on one RNA strand (<xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>; <xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). All controls can be acquired via the European Virus Archive at the following links: Zika virus IVT I available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1598&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1598&#x00026;id_rubrique=9</ext-link>; Zika virus IVT II available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1599&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1599&#x00026;id_rubrique=9</ext-link>; Zika virus IVT III available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1600&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1600&#x00026;id_rubrique=9</ext-link>; Zika virus IVT IV available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1601&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1601&#x00026;id_rubrique=9</ext-link>; Zika virus IVT V available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1602&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1602&#x00026;id_rubrique=9</ext-link>; and uncRNA 1.0 available at: <ext-link ext-link-type="uri" xlink:href="http://www.european-virus-archive.com/Portal/produit.php?ref=1603&#x00026;id_rubrique=9">http://www.european-virus-archive.com/Portal/produit.php?ref=1603&#x00026;id_rubrique=9</ext-link>.</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><p><bold>Genomic locations of oligonucleotides and controls used in real-time reverse transcription polymerase chain reaction assays for Zika virus detection</bold></p></caption><p>E: envelope; M: membrane; NS: nonstructural protein; UTR: untranslated region. </p><p>Notes: Zika virus genomic representation (GenBank&#x000ae; accession no. KU321639), with real-time RT&#x02013;PCR assays identified below by respective first authors or location and corresponding control in vitro transcripts (IVT) and parts of the universal control ribonucleic acid (uncRNA) identified above. Genomic regions not containing published assays so far, but potentially useful for future assay design due to genomic conservation within the Asian Zika virus lineage were also included in the uncRNA. Lower panel, representation of uncRNA and the marker assays, which can detect potential cases of laboratory contamination. The lower limit of detections of the two marker assay variants (both can be used interchangeably for confirmatory analyses) were comparable to Zika virus-specific assays with 4.3 (95% confidence interval, CI: 2.9&#x02013;10.9) and 3.3 (95% CI: 2.4&#x02013;6.5) copies/reaction, respectively. Already published assays are Lanciotti M,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Lanciotti E,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Pyke E,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Pyke NS1,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> PAHO NS2b,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Tappe NS3<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> and Faye NS5.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><graphic xlink:href="BLT.16.175950-F3"/></fig><p>The uncRNA was generated as described previously.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> In brief, the uncRNA was custom designed as a gBlocks&#x000ae; fragment with a T7 promotor sequence (Integrated DNA Technologies, Leuven, Belgium) and in vitro transcribed.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></p><p>A disadvantage of using a test control with a high concentration of viral RNA (e.g. from cell culture) is the potential for laboratory contamination, potentially causing false-positive test results. In contrast to natural viral RNA, potential cases of laboratory contamination with the uncRNA can be proven by two real-time RT&#x02013;PCR marker assays we designed specifically to detect the uncRNA (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). These two marker assays contain detection probes that target the overlap of two joined genomic target domains, which do not naturally occur in the Zika virus genome (<xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>).</p></sec><sec><title>Quantification and characterization</title><p>We purified viral RNA using the Qiagen Viral RNA Mini Kit (Qian, Hilden, Germany) or the MagNA Pure 96 Viral NA Small Volume Kit (Roche, Basel, Switzerland) according to the manufacturer's instructions. Dengue virus RNA quantification and flavivirus typing were done as described previously.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref></p><p>For all of the experiments, except when assessing threshold cycle variation using different reaction conditions and thermocyclers, we quantified Zika virus RNA using the LightCycler&#x000ae; 480 Instrument II (Roche, Basel, Switzerland). Generally, 25&#x000a0;&#x003bc;l reactions were set up with 5&#x000a0;&#x003bc;l of RNA; 12.5&#x000a0;&#x003bc;l of 2&#x02009;&#x000d7;&#x02009;reaction buffer from the Superscript&#x000ae; III one step RT&#x02013;PCR system with Platinum&#x000ae; Taq polymerase (Thermo Fisher Scientific, Darmstadt, Germany); 0.4&#x000a0;&#x003bc;l of a 50&#x000a0;mM magnesium sulfate solution (Thermo Fisher Scientific); 1&#x000a0;&#x003bc;g of nonacetylated bovine serum albumin (Roche), 600&#x000a0;nM of each primer and 280&#x000a0;nM of each probe and 1&#x000a0;&#x003bc;l of SuperScript&#x000ae; III RT/Platinum&#x000ae; Taq mix. Amplification involved 50&#x000a0;&#x000b0;C for 15 minutes, followed by 95&#x000a0;&#x000b0;C for 3&#x000a0;minutes and 45 cycles of 95&#x000a0;&#x000b0;C for 15 seconds, 56&#x000a0;&#x000b0;C for 20 seconds and 72&#x000a0;&#x000b0;C for 15&#x000a0;seconds. For comparison of C<sub>T</sub> values using different PCR cyclers and chemistry, we used the Bonn E- and NS1-based assays using either the Superscript III One-Step RT&#x02013;PCR kit (Thermo Fischer) or the Qiagen&#x000ae; One-Step RT&#x02013;PCR kit (Qiagen) on a Roche LightCycler&#x000ae; 480 and LightCycler 2.0, a Qiagen Rotor Gene HQ and an Applied Biosystems 7500 thermocycler. Reference conditions refer to the usage of Life Technologies SuperScript&#x000ae; III One-Step enzyme mix and a Roche LightCycler&#x000ae; 480 thermocycler as described above.</p><p>Probit regression analyses, to determine the lower limit of detection for all real-time RT&#x02013;PCR assays, were done using SPSS V22 (IBM, Ehningen, Germany) and eight parallel test replicates.</p></sec><sec><title>Clinical specimens</title><p>We obtained clinical specimens from travellers for which routine medical investigation of either Zika or dengue virus had been requested due to compatible clinical symptoms or a travel history to affected countries. The travellers had acquired their infections in Brazil, the Dominican Republic or Suriname during 2015 and 2016.</p><p>We spiked a Zika virus-negative human plasma and urine sample with defined quantities of the African Zika virus strain MR766 and an Asian lineage outbreak strain H/PF/2013. Spiked samples were serially diluted and two replicates of each dilution were individually purified using the MagNA Pure 96 Viral NA Small Volume Kit with an input volume of 200&#x000a0;&#x003bc;L and an extraction volume of 100&#x000a0;&#x003bc;L.</p></sec></sec><sec sec-type="results"><title>Results</title><p>All assay-specific IVT and the uncRNA allowed comparable quantification of Zika virus RNA with a mean twofold deviation of results (maximum deviation: sixfold), suggesting the ability to use these controls to generate comparable results even when different real-time RT&#x02013;PCR assays are used in different laboratories. The two marker assays showed no detection of Zika virus RNA even upon using RNA from high-titred cell culture isolates (10<sup>6</sup>&#x02013;10<sup>9</sup> RNA copies/mL) as a real-time RT&#x02013;PCR template.</p><p>To ensure specific detection of the Zika virus, we evaluated all assays using 37 high-titred cell culture isolates of different flaviviruses or chikungunya virus (the list of tested isolates is available from the corresponding author). None of the published assays detected the co-circulating alphavirus chikungunya virus or any other flavivirus. As expected, an Asian Zika virus lineage-specific E-based assay<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> did not detect the African lineage despite very high concentrations of viral RNA in the sample. As intended, the new NS1-based assay cross-detected Spondweni virus, as well as Kokobera and Jugra virus. These viruses are predominantly animal-associated<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> and do not circulate in Latin America and hence do not affect people in the current Zika virus outbreak.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p><p>When we determined the lower limit of detection using the uncRNA, all but two assays showed comparably high analytical sensitivities of around 5&#x02013;10 Zika virus RNA copies/reaction (<xref ref-type="fig" rid="F4">Fig.&#x000a0;4</xref>). An NS2b-based assay recommended by PAHO showed a lower limit of detection of 17 copies/reaction,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> whereas an NS3-based assay showed a lower limit of detection of 1373 copies/reaction.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> To exemplify the impact of technical sensitivity on clinical sensitivity, we extrapolated the lower limits of detection to clinical viral loads. As shown in <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>, an assay with a lower limit of detection of 5&#x02013;10 copies/reaction has a clinical detection limit of about 1000 copies/mL, whereas an assay with a lower limit of detection of 1000 copies/reaction has a clinical detection limit of about 10000 copies/mL. To improve clinical sensitivity, RNA purification methods could be optimized by using larger input volumes of the clinical samples (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).</p><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4</label><caption><p><bold>Analytical sensitivity of Zika virus real-time reverse transcription polymerase chain reaction assays</bold></p></caption><p>CI: confidence interval; LOD: lower limit of detection.</p><p>Notes: Probability of detection (<italic>y</italic>-axis) is plotted against universal control ribonucleic acid (uncRNA) concentration per reaction in 8 parallel test samples (<italic>x</italic>-axis). The diamonds represent the observed fraction of positive results in parallel experiments. Solid line, predicted proportion of positive results at a given uncRNA input concentration; dashed lines, 95% confidence interval for the prediction. Already published assays are Lanciotti M,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Lanciotti E,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Pyke E,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Pyke NS1,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> PAHO NS2b,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Tappe NS3<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> and Faye NS5.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><graphic xlink:href="BLT.16.175950-F4"/></fig><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Analytical sensitivity of Zika virus real-time reverse transcription polymerase chain reaction assays</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="141" span="1"/><col width="124" span="1"/><col width="138" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Assay, reference</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Technical 95% lower limit of detection, copies per reaction (95% CI)</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Extrapolation of LOD to clinical viral loads, copies/mL<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Assuming a 1:1 concentration during extraction<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Assuming a 2:1 concentration during extraction<sup>a,b</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lanciotti M<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.2 (2.2&#x02013;8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">640</td><td valign="top" align="center" rowspan="1" colspan="1">320</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lanciotti E<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">4.1 (2.7&#x02013;11.4)</td><td valign="top" align="center" rowspan="1" colspan="1">820</td><td valign="top" align="center" rowspan="1" colspan="1">410</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bonn E (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">2.1 (1.4&#x02013;8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">420</td><td valign="top" align="center" rowspan="1" colspan="1">210</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pyke E<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">5.3 (3.0&#x02013;25.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1&#x000a0;100</td><td valign="top" align="center" rowspan="1" colspan="1">530</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pyke NS1<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">12.1 (5.9&#x02013;78.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2&#x000a0;400</td><td valign="top" align="center" rowspan="1" colspan="1">1&#x000a0;210</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bonn NS1 (this study)</td><td valign="top" align="center" rowspan="1" colspan="1">3.1 (2.3&#x02013;5.8)</td><td valign="top" align="center" rowspan="1" colspan="1">620</td><td valign="top" align="center" rowspan="1" colspan="1">310</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAHO NS2b<xref rid="R12" ref-type="bibr"><sup>12</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">17.0 (12.3&#x02013;30.9)</td><td valign="top" align="center" rowspan="1" colspan="1">3&#x000a0;400</td><td valign="top" align="center" rowspan="1" colspan="1">1&#x000a0;700</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tappe NS3<xref rid="R7" ref-type="bibr"><sup>7</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1&#x000a0;377.3 (860.3&#x02013;5&#x000a0;162.4)</td><td valign="top" align="center" rowspan="1" colspan="1">280&#x02009;000</td><td valign="top" align="center" rowspan="1" colspan="1">138&#x02009;000</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Faye NS5<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">8.0 (4.5&#x02013;43.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1&#x000a0;600</td><td valign="top" align="center" rowspan="1" colspan="1">800</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; E: envelope; LOD: lower limit of detection; M: membrane; RNA; ribonucleic acid; NS: nonstructural protein.</p><p><sup>a</sup> Using 5&#x000a0;&#x003bc;L of eluted ribonucleic acid per polymerase chain reaction.</p><p><sup>b</sup> Corresponding to twice higher input (e.g. 140&#x000a0;&#x003bc;l) than elution volumes (e.g. 70&#x000a0;&#x003bc;l), such as those in the commonly used Qiagen Viral RNA Mini Kit (Qiagen, Hilden, Germany), assuming a 100% extraction efficacy.</p></table-wrap-foot></table-wrap><p>We examined the assays&#x02019; sensitivity in different clinical specimens by incorporating the step of RNA purification and using Zika virus-negative human blood and urine samples spiked with 10<sup>2</sup>&#x02013;10<sup>6</sup> copies/mL of either Zika virus representing the Asian lineage (strain H/PF/2013) or the African lineage (strain MR766). The results were consistent with lower limit of detections for the uncRNA. The assays with high analytical sensitivities could detect 10<sup>3</sup> Zika virus RNA copies/mL of blood or urine in at least one replicate experiment, whereas the assay with the lowest analytical sensitivity yielded negative results even at high Zika virus concentrations of 10<sup>5</sup> and 10<sup>6</sup> copies/mL (<xref ref-type="fig" rid="F5">Fig.&#x000a0;5</xref>).</p><fig id="F5" fig-type="figure" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Validation of Zika virus real-time reverse transcription polymerase chain reaction assays</p></caption><p>E: envelope; M: membrane; NS: nonstructural protein; PAHO: Pan American Health Organization; RNA: ribonucleic acid.</p><p>Notes: Already published assays are Lanciotti M,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Lanciotti E,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Pyke E,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Pyke NS1,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> PAHO NS2b,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Tappe NS3<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> and Faye NS5.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><graphic xlink:href="BLT.16.175950-F5"/></fig><p>We explored the variability of the threshold cycle (C<sub>T</sub>) values &#x02013; which could vary due to PCR instruments and reagents used &#x02013; by testing our two new assays under diverse reaction conditions including reagents by different suppliers and different real-time RT&#x02013;PCR instruments. Even a variation of only two variables could yield up to 4.3 cycles in difference in the C<sub>T</sub> values for the same virus target concentration, which corresponds to about 20-fold deviations in viral load results (<xref ref-type="fig" rid="F6">Fig.&#x000a0;6</xref>). Therefore, using C<sub>T</sub> values for comparison of viral loads between studies might be misleading.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref></p><fig id="F6" fig-type="figure" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Threshold cycle variation when using different reaction conditions and thermocyclers</p></caption><p>C<sub>T</sub>: threshold cycle; E: envelope; NS: nonstructural protein.</p><p>Notes: Symbols identify reaction mix and thermocycler yielding different C<sub>T</sub> values (<italic>y</italic>-axis) compared to the standard protocol and thermocycler (<italic>x</italic>-axis).</p><graphic xlink:href="BLT.16.175950-F6"/></fig><p>According to preliminary studies, short-term viremia and low viral loads complicate Zika virus detection in blood.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R26" ref-type="bibr"><sup>26</sup></xref> Since Zika virus RNA has been detected in urine from Zika virus-infected patients for two weeks or longer,<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> we investigated whether blood or urine were the most suitable clinical specimens for diagnoses of acute Zika virus infection. We used the new NS1-based assay to quantify viral loads in 21 serum samples and 12 urine samples from 24 patients infected with virus strains from the current outbreak. As shown in <xref ref-type="fig" rid="F7">Fig.&#x000a0;7</xref>, viral loads generally decreased during 2 to 12 days after symptom onset. Matched urine and blood samples taken on the same day were available from six patients. One patient had a lower viral load in urine, than in blood, two patients had an equal viral load in both samples and three patients had a higher viral load in urine than in blood (<xref ref-type="fig" rid="F8">Fig.&#x000a0;8</xref>). Mean viral loads in all the available clinical samples (including those without known date of symptom onset) were 5x10<sup>4</sup> RNA copies/mL of blood (range: 1x10<sup>2</sup>&#x02013;2x10<sup>6</sup>) and 2x10<sup>4</sup> RNA copies/mL of urine (range: 4x10<sup>2</sup>&#x02013;8x10<sup>4</sup>). The viral loads in the 24 specimens sampled in the first 12 days after symptom onset were comparable to viral loads in serum from patients sampled during the Zika virus outbreak in the Federated States of Micronesia<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> in 2007 (<xref ref-type="fig" rid="F9">Fig.&#x000a0;9</xref>). A combined data set of 41 samples comprising the data from the 2007 outbreak (17 samples)<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> and this study (24 samples) resulted in mean viral loads of 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> RNA copies/mL of blood (range: 1&#x02009;&#x000d7;&#x02009;10<sup>2</sup>&#x02013;4&#x02009;&#x000d7;&#x02009;10<sup>5</sup>) and 5&#x02009;&#x000d7;&#x02009;10<sup>3</sup> RNA copies/mL of urine (range: 4&#x02009;&#x000d7;&#x02009;10<sup>2</sup>&#x02013;6&#x02009;&#x000d7;&#x02009;10<sup>4</sup>). The samples were taken during comparable intervals: within 11 days after symptom onset for urine and within 12 days after symptom onset for serum samples. Two of these 41 samples contained viral loads of less than 5&#x02009;&#x000d7;&#x02009;10<sup>2</sup> RNA copies/mL (<xref ref-type="fig" rid="F9">Fig.&#x000a0;9</xref>), leading to an estimated risk of false-negative test results of 5% even when using highly sensitive assays with a technical lower limit of detection of 5 copies/reaction (equivalent to 5&#x02009;&#x000d7;&#x02009;10<sup>2</sup> copies/mL; <xref ref-type="fig" rid="F10">Fig.&#x000a0;10</xref> and <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>). Using an insensitive assay with a lower limit of detection of 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> copies/reaction, the proportion of estimated false-negative test results is about 50% (<xref ref-type="fig" rid="F10">Fig.&#x000a0;10</xref>).</p><fig id="F7" fig-type="figure" orientation="portrait" position="float"><label>Fig. 7</label><caption><p><bold>Viral loads of Zika virus in clinical specimens</bold></p></caption><p>RNA: ribonucleic acid.</p><p>Note: Viral loads in different types of clinical specimens plotted per day after symptom onset. The Bonn NS1 assay was used for quantification.</p><graphic xlink:href="BLT.16.175950-F7"/></fig><fig id="F8" fig-type="figure" orientation="portrait" position="float"><label>Fig. 8</label><caption><p><bold>Viral loads of Zika virus in paired urine and blood samples</bold></p></caption><p>RNA: ribonucleic acid.</p><p>Notes: Paired urine and blood samples from three patients taken on the same day within the first 10 days after symptom onset. The Bonn NS1 assay was used for quantification.</p><graphic xlink:href="BLT.16.175950-F8"/></fig><fig id="F9" fig-type="figure" orientation="portrait" position="float"><label>Fig. 9</label><caption><p><bold>Comparison of viral loads of Zika virus in blood and urine from different studies</bold></p></caption><p>Cp/rx: copies/reaction; NS: nonstructural protein; RNA: ribonucleic acid.</p><p>Notes: Data from Lanciotti et al. were reported in<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> and data from the Bonn NS1 assay were generated in this study. Lines in plots show mean viral loads.</p><graphic xlink:href="BLT.16.175950-F9"/></fig><fig id="F10" fig-type="figure" orientation="portrait" position="float"><label>Fig. 10</label><caption><p><bold>Risk of false-negative Zika virus test results</bold></p></caption><p>LOD: lower limit of detection.</p><p>Notes: Projection of false-negative test results according to different lower limits of detection for Zika virus, according to a 2:1 input versus elution volume (e.g. 140&#x000a0;&#x000b5;L blood eluted in 70&#x000a0;&#x000b5;L) as in<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> and assuming a 100% extraction efficacy.</p><graphic xlink:href="BLT.16.175950-F10"/></fig><p>Many of the laboratories in countries affected by the current outbreak that are conducting Zika virus testing also have experience in detecting and quantifying dengue virus. To compare the risk of false-negative test results between these two viruses, we quantified 38 clinical samples positive for dengue virus,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> that had been sent to our laboratories for medical diagnostics previously. The mean viral load of dengue was 5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> RNA copies/mL (range: 5&#x02009;&#x000d7;&#x02009;10<sup>2</sup>&#x02013;5&#x02009;&#x000d7;&#x02009;10<sup>8</sup>; <xref ref-type="fig" rid="F11">Fig.&#x000a0;11</xref>), meaning that viral loads of dengue in blood were generally about 100-fold higher than viral loads of Zika virus (<italic>t</italic>-test, <italic>P</italic>&#x02009;=&#x02009;0.03). Accordingly, the estimated risk of false-negative results was several-fold lower for dengue than for the Zika virus (<xref ref-type="fig" rid="F10">Fig.&#x000a0;10</xref> and <xref ref-type="fig" rid="F12">Fig.&#x000a0;12</xref>).</p><fig id="F11" fig-type="figure" orientation="portrait" position="float"><label>Fig. 11</label><caption><p><bold>Viral loads of dengue virus in blood</bold></p></caption><p>Cp/rx: copies/reaction; RNA: ribonucleic acid.</p><p>Note: Lines in plots show mean viral loads.</p><graphic xlink:href="BLT.16.175950-F11"/></fig><fig id="F12" fig-type="figure" orientation="portrait" position="float"><label>Fig. 12</label><caption><p><bold>Risk of false-negative dengue virus test results</bold></p></caption><p>LOD: lower limit of detection.</p><p>Notes: Projection of false-negative test results according to different lower limits of detection for dengue virus, according to a 2:1 input versus elution volume (e.g. 140&#x000a0;&#x000b5;L blood eluted in 70&#x000a0;&#x000b5;L) as in<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> and assuming a 100% extraction efficacy.</p><graphic xlink:href="BLT.16.175950-F12"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>This study provides guidance on the choice of method for diagnosing Zika virus infections and a molecular control that enables the comparison of results between different laboratories and studies. The low viral loads presented in this and a previous study<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> suggest a possibility of false-negative test results when using real-time RT&#x02013;PCR assays in diagnostics.</p><p>The results presented here suggest that some published real-time RT&#x02013;PCR assays may be of limited use for clinical diagnostics during the current Zika virus outbreak. One NS3-based assay that was intended for virus typing should not be used for diagnostics because of its low sensitivity.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> Some other assays have features that potentially limit their use in the current outbreak, including limited access to specific probe formats (e.g. the Faye NS5-based assay),<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> relatively lower analytical sensitivity and high numbers of potential mismatches with members of the Asian Zika virus lineage.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> Our novel assays may be more robust against genetic variation, but real-time monitoring of all assays&#x02019; oligonucleotide binding regions is required during the current situation. According to our data, the Lanciotti E-,<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> the Pyke E- and NS1-,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> the Bonn E- and the Bonn NS1-based assays are highly sensitive for the Asian Zika virus lineage and show few mismatches within genomic domains targeted by these assays. With the present knowledge of Zika virus variability, we suggest that laboratories can use these five assays for diagnostics during the current outbreak and preferably combine at least two assays to increase clinical sensitivity.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p><p>The low viral loads we detected in urine and blood samples are in agreement with two previous studies reporting quantitative data.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R26" ref-type="bibr"><sup>26</sup></xref> In contrast to data from six patients from French Polynesia,<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> we did not observe a significant difference in the viral loads between the urine and blood samples. Hence, our data do not support urine as a generally more suitable clinical specimen to detect the Zika virus. However, since Zika virus RNA seems to remain detectable in urine and semen longer than in blood,<xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>&#x02013;</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> we suggest that both blood and urine samples should be used for reliable Zika virus diagnostics. The Zika virus has also been detected in saliva,<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>,</sup><xref rid="R30" ref-type="bibr"><sup>30</sup></xref> but we could not evaluate the suitability of saliva samples because we did not have access to such samples.</p><p>Although commercial diagnostic real-time RT&#x02013;PCR reagents for Zika virus detection are available, laboratories in areas affected by the Zika virus outbreak often use non-commercial formulations because of resource constraints.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> The non-commercial assays are difficult to standardize and compare. The transfer of essential reagents with coordinated implementation of laboratory protocols and practical training for staff can strengthen accurate real-time RT&#x02013;PCR diagnostics in resource-constrained settings.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>&#x02013;</sup><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> Among the most essential contributions to technology transfer is the provision of standardized control material that can be shipped internationally without biosafety concerns. Research consortia and public health structures can use these reagents to establish a technical basis for test implementation, as demonstrated for severe acute respiratory syndrome and Middle East respiratory syndrome-coronaviruses.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> When these viruses emerged, they were novel and new diagnostic tests had to be developed along with the provision of reagents to laboratories. However, for the detection of the Zika virus, where test formulations are already available, assay standardization can only work with the provision of a reference reagent that is universally applicable in all assays, such as our uncRNA reagent or a multicentre validated natural virus standard. Quantitative comparability between studies will enable relative estimates of the transmission risks associated with blood transfusion and solid organ transplantations as well as the transmission risks from body fluids such as semen or saliva. Quantitative data may also shed light on Zika virus pathogenesis, since a higher viral load may be associated with more severe clinical complications, as shown in other arboviral infections, such as those caused by dengue, chikungunya and Crimean-Congo haemorrhagic fever viruses.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>&#x02013;</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref></p><p>Low viral loads in patients imply a high risk of false-negative test results. Until 7 April 2016, only 3% of 199&#x02009;922 suspected Zika virus cases could be laboratory-confirmed in the PAHO Region.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> The low number of confirmed cases could be due to the difficulty in processing high numbers of diagnostic requests in resource-constrained settings. A study from Puerto Rico, showed that 30 (19%) of 155 patients with suspected Zika virus disease could be laboratory-confirmed using molecular and serologic tools.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> In addition, a study from Brazil demonstrated that 119 (45%) of 262 patients with suspected Zika virus infection had a positive real-time RT&#x02013;PCR result.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> The higher proportion of laboratory-confirmed cases in those studies and our data suggest that a considerable proportion of patients with low viral loads may have gone undiagnosed by molecular testing during the current outbreak.</p><p>Endemic countries also need highly sensitive molecular Zika virus detection methods to ensure safe blood transfusions. The Zika virus has been detected in 3% of blood donors in previous outbreaks<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> and transfusion-associated transmission has been reported in Brazil.<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> Our comparison of blood viral loads and real-time RT&#x02013;PCR sensitivity suggest a risk of false-negative results during pooled and even individual blood donor screening. Such risk has been reported for the West Nile virus, where several people have acquired the virus through blood transfusion or solid organ transplantation, because of false-negative real-time RT&#x02013;PCR results.<xref rid="R44" ref-type="bibr"><sup>44</sup></xref></p><p>The association of Zika virus infection and fetal malformations demand reliable Zika virus diagnostics for pregnant women.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref> The current sensitivity of real-time RT&#x02013;PCR assays suggests that molecular testing during pregnancy may preferentially diagnose highly viremic pregnant women. If intrauterine Zika virus infections and the congenital malformations correlate positively with high Zika virus concentrations, the limited test sensitivity might influence estimates of the manifestation index of congenital disease. The low viral loads in many patients suggest a limited capacity for molecular protocols to exclude Zika virus infection in highly affected areas. Hence, cohort studies investigating Zika virus pathogenesis in pregnant women need to do additional serological testing.</p><p>In conclusion, our data emphasize the need for highly sensitive assays in molecular Zika virus diagnostics. In addition to an appropriate choice of method, clinical sensitivity can be increased by testing several specimens per patient, by using more than one real-time RT&#x02013;PCR target, optimizing RNA purification from clinical samples and by combining molecular and serological testing.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> The uncRNA reagent &#x02013; used as a universal quantitative positive control &#x02013; can ensure high sensitivity and good comparability of qualitative and quantitative results in diagnostic laboratories and clinical studies.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank Janett Wieseler, Sandra Junglen and Annemiek van der Eijk. Cecile Baronti and Xavier de Lamballerie are also affiliated with Institute Hospitalo-Universitaire M&#x000e9;diterran&#x000e9;e Infection, Marseille, France. Victor M Corman, Andrea Rasche, Jonas Schmidt-Chanasit, Christian Drosten and Jan Felix Drexler are also affiliated with the German Centre for Infection Research, Germany.</p></ack><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>This study was supported by funding from the European Commission through the Horizon 2020 project EVAg (European Virus Archive goes global), grant agreement number 653316 and the framework program (FP)7 project PREPARE (Platform for European Preparedness Against (Re-emerging Epidemics), grant agreement number 602525.</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Kuno</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>GJ</given-names></string-name>. <article-title>Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses.</article-title>
<source>Arch Virol</source>. <year>2007</year>;<volume>152</volume>(<issue>4</issue>):<fpage>687</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-006-0903-z</pub-id><pub-id pub-id-type="pmid">17195954</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Duffy</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Hancock</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Powers</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kool</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Lanciotti</surname>
<given-names>RS</given-names></string-name>, <etal>et al.</etal>
<article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia.</article-title>
<source>N Engl J Med</source>. <year>2009</year>
<month>6</month>
<day>11</day>;<volume>360</volume>(<issue>24</issue>):<fpage>2536</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0805715</pub-id><pub-id pub-id-type="pmid">19516034</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Gatherer</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kohl</surname>
<given-names>A</given-names></string-name>. <article-title>Zika virus: a previously slow pandemic spreads rapidly through the Americas.</article-title>
<source>J Gen Virol</source>. <year>2016</year>
<month>2</month>;<volume>97</volume>(<issue>2</issue>):<fpage>269</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1099/jgv.0.000381</pub-id><pub-id pub-id-type="pmid">26684466</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Cao-Lormeau</surname>
<given-names>VM</given-names></string-name>, <string-name><surname>Blake</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mons</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Last&#x000e8;re</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Roche</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vanhomwegen</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Guillain-Barr&#x000e9; Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.</article-title>
<source>Lancet</source>. <year>2016</year>
<month>4</month>
<day>9</day>;<volume>387</volume>(<issue>10027</issue>):<fpage>1531</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00562-6</pub-id><pub-id pub-id-type="pmid">26948433</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Carteaux</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Maquart</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bedet</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Contou</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Brugi&#x000e8;res</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Fourati</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Zika Virus associated with meningoencephalitis.</article-title>
<source>N Engl J Med</source>. <year>2016</year>
<month>4</month>
<day>21</day>;<volume>374</volume>(<issue>16</issue>):<fpage>1595</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1602964</pub-id><pub-id pub-id-type="pmid">26958738</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Furtado</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Esp&#x000f3;sito</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Klein</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Teixeira-Pinto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>da Fonseca</surname>
<given-names>BA</given-names></string-name>. <article-title>Uveitis associated with Zika virus infection.</article-title>
<source>N Engl J Med</source>. <year>2016</year>
<month>7</month>
<day>28</day>;<volume>375</volume>(<issue>4</issue>):<fpage>394</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1603618</pub-id><pub-id pub-id-type="pmid">27332784</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Tappe</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nachtigall</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kapaun</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schnitzler</surname>
<given-names>P</given-names></string-name>, <string-name><surname>G&#x000fc;nther</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schmidt-Chanasit</surname>
<given-names>J</given-names></string-name>. <article-title>Acute Zika virus infection after travel to Malaysian Borneo, September 2014.</article-title>
<source>Emerg Infect Dis</source>. <year>2015</year>
<month>5</month>;<volume>21</volume>(<issue>5</issue>):<fpage>911</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.3201/eid2105.141960</pub-id><pub-id pub-id-type="pmid">25898277</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Calvet</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Aguiar</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Melo</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Sampaio</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>de Filippis</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fabri</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study.</article-title>
<source>Lancet Infect Dis</source>. <year>2016</year>
<month>6</month>;<volume>16</volume>(<issue>6</issue>):<fpage>653</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(16)00095-5</pub-id><pub-id pub-id-type="pmid">26897108</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Mlakar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Korva</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tul</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Popovi&#x00107;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Polj&#x00161;ak-Prijatelj</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mraz</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Zika virus associated with microcephaly.</article-title>
<source>N Engl J Med</source>. <year>2016</year>
<month>3</month>
<day>10</day>;<volume>374</volume>(<issue>10</issue>):<fpage>951</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1600651</pub-id><pub-id pub-id-type="pmid">26862926</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Brasil</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pereira</surname>
<given-names>JP</given-names>
<suffix>Jr</suffix></string-name>, <string-name><surname>Raja Gabaglia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Damasceno</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wakimoto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ribeiro Nogueira</surname>
<given-names>RM</given-names></string-name>, <etal>et al.</etal>
<article-title>Zika virus infection in pregnant women in Rio de Janeiro &#x02013; preliminary report.</article-title>
<source>N Engl J Med</source>. <year>2016</year>
<month>3</month>
<day>4</day>;<fpage>NEJMoa1602412</fpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1602412</pub-id><pub-id pub-id-type="pmid">26943629</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Rasmussen</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Jamieson</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Honein</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>LR</given-names></string-name>. <article-title>Zika Virus and birth defects&#x02013;reviewing the evidence for causality.</article-title>
<source>N Engl J Med</source>. <year>2016</year>
<month>5</month>
<day>19</day>;<volume>374</volume>(<issue>20</issue>):<fpage>1981</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsr1604338</pub-id><pub-id pub-id-type="pmid">27074377</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Waggoner</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Pinsky</surname>
<given-names>BA</given-names></string-name>. <article-title>Zika virus: diagnostics for an emerging pandemic threat.</article-title>
<source>J Clin Microbiol</source>. <year>2016</year>
<month>4</month>;<volume>54</volume>(<issue>4</issue>):<fpage>860</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00279-16</pub-id><pub-id pub-id-type="pmid">26888897</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Lanciotti</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Kosoy</surname>
<given-names>OL</given-names></string-name>, <string-name><surname>Laven</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Velez</surname>
<given-names>JO</given-names></string-name>, <string-name><surname>Lambert</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>AJ</given-names></string-name>, <etal>et al.</etal>
<article-title>Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.</article-title>
<source>Emerg Infect Dis</source>. <year>2008</year>
<month>8</month>;<volume>14</volume>(<issue>8</issue>):<fpage>1232</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1408.080287</pub-id><pub-id pub-id-type="pmid">18680646</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Charrel</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Leparc-Goffart</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Pas</surname>
<given-names>S</given-names></string-name>, <string-name><surname>de Lamballerie</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Koopmans</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Reusken</surname>
<given-names>C</given-names></string-name>. <article-title>Background review for diagnostic test development for Zika virus infection.</article-title>
<source>Bull World Health Organ</source>. <year>2016</year>
<month>8</month>
<day>1</day>;<volume>94</volume>(<issue>8</issue>):<fpage>574</fpage>&#x02013;<lpage>584D</lpage>. <pub-id pub-id-type="doi">10.2471/BLT.16.171207</pub-id><pub-id pub-id-type="pmid">27516635</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Faye</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Faye</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Diallo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Diallo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Weidmann</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sall</surname>
<given-names>AA</given-names></string-name>. <article-title>Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes.</article-title>
<source>Virol J</source>. <year>2013</year>
<month>10</month>
<day>22</day>;<volume>10</volume>(<issue>1</issue>):<fpage>311</fpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-10-311</pub-id><pub-id pub-id-type="pmid">24148652</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Pyke</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Daly</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Cameron</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>PR</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Hewitson</surname>
<given-names>GR</given-names></string-name>, <etal>et al.</etal>
<article-title>Imported zika virus infection from the Cook Islands into Australia, 2014.</article-title>
<source>PLoS Curr</source>. <year>2014</year>
<month>6</month>
<day>02</day>;<volume>6</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">24944843</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Drexler</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>de Souza Luna</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Pedroso</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pedral-Sampaio</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Queiroz</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Brites</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>
<article-title>Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.</article-title>
<source>J Clin Microbiol</source>. <year>2007</year>
<month>6</month>;<volume>45</volume>(<issue>6</issue>):<fpage>2061</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00136-07</pub-id><pub-id pub-id-type="pmid">17392448</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Simmonds</surname>
<given-names>P</given-names></string-name>. <article-title>SSE: a nucleotide and amino acid sequence analysis platform.</article-title>
<source>BMC Res Notes</source>. <year>2012</year>
<month>1</month>
<day>20</day>;<volume>5</volume>(<issue>1</issue>):<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/1756-0500-5-50</pub-id><pub-id pub-id-type="pmid">22264264</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Kwok</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kellogg</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>McKinney</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Spasic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Goda</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Levenson</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>
<article-title>Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies.</article-title>
<source>Nucleic Acids Res</source>. <year>1990</year>
<month>2</month>
<day>25</day>;<volume>18</volume>(<issue>4</issue>):<fpage>999</fpage>&#x02013;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1093/nar/18.4.999</pub-id><pub-id pub-id-type="pmid">2179874</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Drexler</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Kupfer</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Grotto</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Rodrigues</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Grywna</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>A novel diagnostic target in the hepatitis C virus genome.</article-title>
<source>PLoS Med</source>. <year>2009</year>
<month>2</month>
<day>10</day>;<volume>6</volume>(<issue>2</issue>):<fpage>e31</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000031</pub-id><pub-id pub-id-type="pmid">19209955</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Drosten</surname>
<given-names>C</given-names></string-name>, <string-name><surname>G&#x000f6;ttig</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schilling</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Asper</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Panning</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schmitz</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.</article-title>
<source>J Clin Microbiol</source>. <year>2002</year>
<month>7</month>;<volume>40</volume>(<issue>7</issue>):<fpage>2323</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.40.7.2323-2330.2002</pub-id><pub-id pub-id-type="pmid">12089242</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Moureau</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Temmam</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gonzalez</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Charrel</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Grard</surname>
<given-names>G</given-names></string-name>, <string-name><surname>de Lamballerie</surname>
<given-names>X</given-names></string-name>. <article-title>A real-time RT&#x02013;PCR method for the universal detection and identification of flaviviruses.</article-title>
<source>Vector Borne Zoonotic Dis</source>. <year>2007</year> Winter;<volume>7</volume>(<issue>4</issue>):<fpage>467</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1089/vbz.2007.0206</pub-id><pub-id pub-id-type="pmid">18020965</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Kitchen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shackelton</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Holmes</surname>
<given-names>EC</given-names></string-name>. <article-title>Family level phylogenies reveal modes of macroevolution in RNA viruses.</article-title>
<source>Proc Natl Acad Sci USA</source>. <year>2011</year>
<month>1</month>
<day>4</day>;<volume>108</volume>(<issue>1</issue>):<fpage>238</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1011090108</pub-id><pub-id pub-id-type="pmid">21173251</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Mackay</surname>
<given-names>IM</given-names></string-name>. <article-title>Real-time PCR in the microbiology laboratory.</article-title>
<source>Clin Microbiol Infect</source>. <year>2004</year>
<month>3</month>;<volume>10</volume>(<issue>3</issue>):<fpage>190</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1111/j.1198-743X.2004.00722.x</pub-id><pub-id pub-id-type="pmid">15008940</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Donald</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Qureshi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Burns</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Holden</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Blasic</surname>
<given-names>JR Jr</given-names></string-name>, <string-name><surname>Woolford</surname>
<given-names>AJ</given-names></string-name>. <article-title>An inter-platform repeatability study investigating real-time amplification of plasmid DNA.</article-title>
<source>BMC Biotechnol</source>. <year>2005</year>
<month>5</month>
<day>25</day>;<volume>5</volume>(<issue>1</issue>):<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6750-5-15</pub-id><pub-id pub-id-type="pmid">15916714</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Gourinat</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>O&#x02019;Connor</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Calvez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Goarant</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dupont-Rouzeyrol</surname>
<given-names>M</given-names></string-name>. <article-title>Detection of Zika virus in urine.</article-title>
<source>Emerg Infect Dis</source>. <year>2015</year>
<month>1</month>;<volume>21</volume>(<issue>1</issue>):<fpage>84</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3201/eid2101.140894</pub-id><pub-id pub-id-type="pmid">25530324</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Atkinson</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hearn</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Afrough</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Lumley</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Carter</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Aarons</surname>
<given-names>EJ</given-names></string-name>, <etal>et al.</etal>
<article-title>Detection of Zika virus in semen.</article-title>
<source>Emerg Infect Dis</source>. <year>2016</year>
<month>5</month>;<volume>22</volume>(<issue>5</issue>):<fpage>940</fpage>.<pub-id pub-id-type="pmid">27088817</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Barzon</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pacenti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Berto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sinigaglia</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Franchin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lavezzo</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016.</article-title>
<source>Euro Surveill</source>. <year>2016</year>;<volume>21</volume>(<issue>10</issue>):<fpage>30159</fpage>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2016.21.10.30159</pub-id><pub-id pub-id-type="pmid">26987769</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Campos</surname>
<given-names>RdeM</given-names></string-name>, <string-name><surname>Cirne-Santos</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Meira</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Santos</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>de Meneses</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Friedrich</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Prolonged detection of Zika virus RNA in urine samples during the ongoing Zika virus epidemic in Brazil.</article-title>
<source>J Clin Virol</source>. <year>2016</year>
<month>4</month>;<volume>77</volume>:<fpage>69</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2016.02.009</pub-id><pub-id pub-id-type="pmid">26921737</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Musso</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Roche</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Nhan</surname>
<given-names>TX</given-names></string-name>, <string-name><surname>Robin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Teissier</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cao-Lormeau</surname>
<given-names>VM</given-names></string-name>. <article-title>Detection of Zika virus in saliva.</article-title>
<source>J Clin Virol</source>. <year>2015</year>
<month>7</month>;<volume>68</volume>:<fpage>53</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2015.04.021</pub-id><pub-id pub-id-type="pmid">26071336</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Drosten</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Panning</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Drexler</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>H&#x000e4;nsel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Pedroso</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Yeats</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5&#x02032; long terminal repeat domain.</article-title>
<source>Clin Chem</source>. <year>2006</year>
<month>7</month>;<volume>52</volume>(<issue>7</issue>):<fpage>1258</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2006.066498</pub-id><pub-id pub-id-type="pmid">16627558</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>St&#x000f6;cker</surname>
<given-names>A</given-names></string-name>, <string-name><surname>de Carvalho Dominguez Souza</surname>
<given-names>BF</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>TCM</given-names></string-name>, <string-name><surname>Netto</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Araujo</surname>
<given-names>LO</given-names></string-name>, <string-name><surname>Corr&#x000ea;a</surname>
<given-names>JI</given-names></string-name>, <etal>et al.</etal>
<article-title>Cosavirus infection in persons with and without gastroenteritis, Brazil.</article-title>
<source>Emerg Infect Dis</source>. <year>2012</year>
<month>4</month>;<volume>18</volume>(<issue>4</issue>):<fpage>656</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1804.111415</pub-id><pub-id pub-id-type="pmid">22469070</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Panning</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Charrel</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Donoso Mantke</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Landt</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Niedrig</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Drosten</surname>
<given-names>C</given-names></string-name>. <article-title>Coordinated implementation of chikungunya virus reverse transcription-PCR.</article-title>
<source>Emerg Infect Dis</source>. <year>2009</year>
<month>3</month>;<volume>15</volume>(<issue>3</issue>):<fpage>469</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.3201/eid1503.081104</pub-id><pub-id pub-id-type="pmid">19239767</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Corman</surname>
<given-names>VM</given-names></string-name>, <string-name><surname>Eckerle</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Bleicker</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zaki</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Landt</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Eschbach-Bludau</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.</article-title>
<source>Euro Surveill</source>. <year>2012</year>
<month>9</month>
<day>27</day>;<volume>17</volume>(<issue>39</issue>):<fpage>20285</fpage>.<pub-id pub-id-type="pmid">23041020</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Drosten</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Doerr</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>W</given-names></string-name>, <string-name><surname>St&#x000f6;hr</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Niedrig</surname>
<given-names>M</given-names></string-name>. <article-title>SARS molecular detection external quality assurance.</article-title>
<source>Emerg Infect Dis</source>. <year>2004</year>
<month>12</month>;<volume>10</volume>(<issue>12</issue>):<fpage>2200</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.3201/eid1012.040416</pub-id><pub-id pub-id-type="pmid">15663861</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Vaughn</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kalayanarooj</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Innis</surname>
<given-names>BL</given-names></string-name>, <string-name><surname>Nimmannitya</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Suntayakorn</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.</article-title>
<source>J Infect Dis</source>. <year>2000</year>
<month>1</month>;<volume>181</volume>(<issue>1</issue>):<fpage>2</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1086/315215</pub-id><pub-id pub-id-type="pmid">10608744</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Hoarau</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Jaffar Bandjee</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Krejbich Trotot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Das</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Li-Pat-Yuen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dassa</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal>
<article-title>Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.</article-title>
<source>J Immunol</source>. <year>2010</year>
<month>5</month>
<day>15</day>;<volume>184</volume>(<issue>10</issue>):<fpage>5914</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900255</pub-id><pub-id pub-id-type="pmid">20404278</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Duh</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Saksida</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Petrovec</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ahmeti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dedushaj</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Panning</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Viral load as predictor of Crimean-Congo hemorrhagic fever outcome.</article-title>
<source>Emerg Infect Dis</source>. <year>2007</year>
<month>11</month>;<volume>13</volume>(<issue>11</issue>):<fpage>1769</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3201/eid1311.070222</pub-id><pub-id pub-id-type="pmid">18217568</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="book"><source>Cumulative Zika suspected and confirmed cases reported by countries and territories in the Americas, 2015&#x02013;2016 updated 7 April 2016.</source>
<publisher-loc>Washington and Geneva</publisher-loc>: <publisher-name>Pan American Health Association and World Health Organization</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Thomas</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Sharp</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Torres</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Armstrong</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Munoz-Jordan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ryff</surname>
<given-names>KR</given-names></string-name>, <etal>et al.</etal>
<article-title>Local transmission of Zika virus&#x02013;Puerto Rico, November 23, 2015-January 28, 2016.</article-title>
<source>MMWR Morb Mortal Wkly Rep</source>. <year>2016</year>
<month>2</month>
<day>19</day>;<volume>65</volume>(<issue>6</issue>):<fpage>154</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6506e2</pub-id><pub-id pub-id-type="pmid">26890470</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Brasil</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Calvet</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Siqueira</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Wakimoto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>de Sequeira</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Nobre</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Zika virus outbreak in Rio de Janeiro, Brazil: clinical characterization, epidemiological and virological aspects.</article-title>
<source>PLoS Negl Trop Dis</source>. <year>2016</year>
<month>4</month>
<day>12</day>;<volume>10</volume>(<issue>4</issue>):<fpage>e0004636</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0004636</pub-id><pub-id pub-id-type="pmid">27070912</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Musso</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nhan</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Robin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Roche</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bierlaire</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zisou</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014.</article-title>
<source>Euro Surveill</source>. <year>2014</year>
<month>4</month>
<day>10</day>;<volume>19</volume>(<issue>14</issue>):<fpage>20761</fpage>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES2014.19.14.20761</pub-id><pub-id pub-id-type="pmid">24739982</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="web">Maintaining a safe and adequate blood supply during Zika virus outbreaks. Interim guidance [WHO/ZIKV/HS/16.1]. Geneva: World Health Organization; February 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://who.int/csr/resources/publications/zika/Safe-blood_supply18Feb2016.pdf">http://who.int/csr/resources/publications/zika/Safe-blood_supply18Feb2016.pdf</ext-link> [cited 2016 Feb 23].</mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Dodd</surname>
<given-names>RY</given-names></string-name>, <string-name><surname>Foster</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Stramer</surname>
<given-names>SL</given-names></string-name>. <article-title>Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012.</article-title>
<source>Transfus Med Rev</source>. <year>2015</year>
<month>7</month>;<volume>29</volume>(<issue>3</issue>):<fpage>153</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.tmrv.2015.03.001</pub-id><pub-id pub-id-type="pmid">25841631</pub-id></mixed-citation></ref></ref-list></back></article>